This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 01 Mar 2022  |  Europe  |  Mega Trends

    European Clinical Laboratory Services Growth Opportunity

    Customer Experience Driven by New B2B and B2C Business Models

    Diagnostics is the backbone of the healthcare sector. According to a World Health Organization (WHO) study, although the segment accounts for less than 5% of hospital costs, its findings influence 60–70% of healthcare decision-making. Diagnostics helps to analyze medical conditions and guide patients toward the right medication, treatment, or sur...

    $2,450.00
  2. 28 Feb 2022  |  North America  |  Mega Trends

    United States Clinical Laboratory Services Growth Opportunities

    Advanced Molecular Diagnostics and At-Home Testing are Growth Prerequisites

    The United States spends more than $3 trillion—nearly 18% of GDP—on healthcare, a massive sector. Healthcare value chain participants face dynamic environments that several trends impact, including the rise in the aging population (16.9% in 2020); chronic disease burden; regulatory challenges; integration across the care continuum; migration to...

    $2,450.00
  3. 22 Feb 2022  |  North America  |  Mega Trends

    United States Liquid Biopsy Growth Opportunities

    Non-invasive Liquid Biopsy Technology Shapes the Precision Diagnostics Landscape

    Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio. Advances in next-generation sequencing-based companion diagnosti...

    $4,950.00
  4. 15 Feb 2022  |  North America  |  Mega Trends

    Global Biologics Contract Development and Manufacturing Organization Profiles and Growth Opportunities

    The Contract Research, Development, and Manufacturing Organization Business Model to Drive Future Growth Potential

    Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...

    $2,450.00
  5. This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends in genetic engineering techniques across the United States. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of gene...

    $250.00
  6. 16 Sep 2016  |  Global  |  Technology Alert

    Medical Device Innovations in San Diego - Medical Device TOE

    This edition of the Medical Device TOE depicts the current landscape and the new regional innovative trends in San Diego. Innovations in medical devices companies in San Diego are illustrated along with examples of few industry participants. The Medical Device TechVision Opportunity Engine (TOE) analyzes and reports on new and emerging technologi...

    $950.00
  7. 16 Sep 2016  |  Global  |  Technology Alert

    Collaborations across Immunotherapy - Genetic TOE

    This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across immunotherapy. The corresponding patent scenario is depicted along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportun...

    $250.00
  8. 09 Sep 2016  |  Global  |  Technology Alert

    The Pharmaceutical Landscape in South Africa - Drug Discovery TOE

    This edition of the Drug Discovery TOE depicts the current landscape and the new life sciences trends across the pharmaceutical industry in South Africa. South Africa has a diversified manufacturing industry that focuses on production of pharmaceutical and biotechnology products. Critical programmes were launched by the Department of Trade and Indu...

    $950.00
  9. The latest edition of the Medical Diagnostics and Imaging TOE depicts the current landscape and new trends across fluoroscopic imaging devices. Novel digital imaging solutions for fluoroscopy and radiography along with industry interactions have been presented. Medical and Diagnostic Imaging TechVision Opportunity Engine (TOE)'s mission is to anal...

    $950.00
  10. 26 Aug 2016  |  Global  |  Technology Alert

    Genomic- and Cellular-based Innovations - Genetic TOE

    This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across genomic- and cellular-based innovations. The corresponding patent scenario is depicted, along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances w...

    $250.00